121 related articles for article (PubMed ID: 33125593)
1. Parameter perturbations in a post-treatment chronic myeloid leukemia model capture the essence of pre-diagnosis A-bomb survivor mysteries.
Radivoyevitch T
Radiat Environ Biophys; 2021 Mar; 60(1):41-47. PubMed ID: 33125593
[TBL] [Abstract][Full Text] [Related]
2. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia.
Radivoyevitch T; Hoel DG
Radiat Environ Biophys; 2000 Sep; 39(3):153-9. PubMed ID: 11095145
[TBL] [Abstract][Full Text] [Related]
3. Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data.
Radivoyevitch T; Hoel DG
Math Biosci; 1999; 162(1-2):85-101. PubMed ID: 10616282
[TBL] [Abstract][Full Text] [Related]
4. Chronic myeloid leukemia: Two mysteries.
Radivoyevitch T; Jorgensen TN; Lindner DJ; Maciejewski JP; Miyazaki Y; Gale RP
Leuk Res; 2019 Apr; 79():3-5. PubMed ID: 30780032
[No Abstract] [Full Text] [Related]
5. Is the primary event in radiation-induced chronic myelogenous leukemia the induction of the t(9;22) translocation?
Holmberg M
Leuk Res; 1992; 16(4):333-6. PubMed ID: 1564937
[TBL] [Abstract][Full Text] [Related]
6. Biologically based risk estimation for radiation-induced CML. Inferences from BCR and ABL geometric distributions.
Radivoyevitch T; Kozubek S; Sachs RK
Radiat Environ Biophys; 2001 Mar; 40(1):1-9. PubMed ID: 11357705
[TBL] [Abstract][Full Text] [Related]
7. [Clinical epidemiology].
Ohyashiki K
Nihon Rinsho; 2001 Dec; 59(12):2416-20. PubMed ID: 11766349
[TBL] [Abstract][Full Text] [Related]
8. Atomic bomb and leukemia.
Ichimaru M; Tomonaga M; Amenomori T; Matsuo T
J Radiat Res; 1991 Dec; 32 Suppl 2():14-9. PubMed ID: 1823351
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
10. 9;22 translocation and bcr rearrangements in chronic myelocytic leukemia patients among atomic bomb survivors.
Tanaka K; Takechi M; Hong J; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Dohy H; Kyo T
J Radiat Res; 1989 Dec; 30(4):352-8. PubMed ID: 2614751
[TBL] [Abstract][Full Text] [Related]
11. Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors.
Matsuo T; Nakashima E; Carter RL; Neriishi K; Mabuchi K; Akiyama M; Shimaoka K; Kinoshita K; Tomonaga M; Ichimaru M
J Radiat Res; 1995 Mar; 36(1):8-16. PubMed ID: 7616489
[TBL] [Abstract][Full Text] [Related]
12. [Radiation-related CML].
Kamada N
Nihon Rinsho; 2001 Dec; 59(12):2329-35. PubMed ID: 11766334
[TBL] [Abstract][Full Text] [Related]
13. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.
Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S
Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) cytotoxic T-cell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR-restricted manner.
Yasukawa M; Ohminami H; Kaneko S; Yakushijin Y; Nishimura Y; Inokuchi K; Miyakuni T; Nakao S; Kishi K; Kubonishi I; Dan K; Fujita S
Blood; 1998 Nov; 92(9):3355-61. PubMed ID: 9787173
[TBL] [Abstract][Full Text] [Related]
15. Quantitative modeling of chronic myeloid leukemia: insights from radiobiology.
Radivoyevitch T; Hlatky L; Landaw J; Sachs RK
Blood; 2012 May; 119(19):4363-71. PubMed ID: 22353999
[TBL] [Abstract][Full Text] [Related]
16. The allometry of chronic myeloid leukemia.
Pacheco JM; Traulsen A; Dingli D
J Theor Biol; 2009 Aug; 259(3):635-40. PubMed ID: 19362566
[TBL] [Abstract][Full Text] [Related]
17. High incidence of meningioma among Hiroshima atomic bomb survivors.
Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
[TBL] [Abstract][Full Text] [Related]
18. A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells.
Zorn E; Orsini E; Wu CJ; Stein B; Chillemi A; Canning C; Alyea EP; Soiffer RJ; Ritz J
Transplantation; 2001 Apr; 71(8):1131-7. PubMed ID: 11374415
[TBL] [Abstract][Full Text] [Related]
19. What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?
Radivoyevitch T; Gale RP; Kalaycio ME
Leukemia; 2024 Jan; 38(1):207-209. PubMed ID: 37949937
[No Abstract] [Full Text] [Related]
20. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
Pavithran K; Doval DC
Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
